ARTICLE | Company News
Seaside Therapeutics, Roche deal
June 25, 2012 7:00 AM UTC
Roche and Seaside partnered to develop disease modifying treatments for fragile X syndrome and autism spectrum disorders. Seaside will grant Roche an exclusive license to IP covering metabotropic glu...